Mar 23, 2020 4:35pm EDT DiaMedica Therapeutics Announces 2019 Financial Results and Provides Business Update
Mar 17, 2020 8:10am EDT DiaMedica Therapeutics to Report Fourth Quarter 2019 Financials and Provide a Business Update March 24, 2020
Mar 09, 2020 8:10am EDT DiaMedica Therapeutics to Participate at 32nd Annual ROTH Conference on March 15-17, 2020
Feb 13, 2020 4:35pm EST DiaMedica Therapeutics Announces Closing of $8.5 Million Public Offering of Common Shares
Dec 17, 2019 4:14pm EST DiaMedica Therapeutics Announces First Patient Dosed in REDUX Phase II Clinical Trial of DM199 for the Treatment of Chronic Kidney Disease
Nov 13, 2019 4:12pm EST DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update
Nov 06, 2019 4:04pm EST DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019
Nov 05, 2019 4:04pm EST DiaMedica Therapeutics to Participate in 10th Annual Craig-Hallum Alpha Select Conference
Oct 14, 2019 7:42am EDT DiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney Disease
